{"id":"NCT01311648","sponsor":"Bayer","briefTitle":"BAY81-8973 Pediatric Safety and Efficacy Trial","officialTitle":"A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06-09","primaryCompletion":"2019-09-09","completion":"2020-10-27","firstPosted":"2011-03-09","resultsPosted":"2020-11-03","lastUpdate":"2023-12-05"},"enrollment":94,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Haemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"Recombinant Factor VIII (Kovaltry, BAY81-8973)","otherNames":[]},{"type":"BIOLOGICAL","name":"Recombinant Factor VIII (Kovaltry, BAY81-8973)","otherNames":[]}],"arms":[{"label":"PTPs 0-12 years","type":"EXPERIMENTAL"},{"label":"PUPs/MTPs 0-<6 years","type":"EXPERIMENTAL"}],"summary":"The primary objective was to evaluate the safety and efficacy of the treatment with BAY81-8973 for prophylaxis and treatment of breakthrough bleeds in children with severe hemophilia A.\n\nThe secondary objectives were\n\n* To assess the safety and efficacy of BAY81-8973 during surgeries.\n* To assess incremental recovery of BAY81-8973.\n* To assess pharmacokinetic (PK) parameters in a subset of children (Previously treated patients \\[PTPs\\] and previously untreated patients \\[PUPs\\] / minimally treated patients \\[MTPs\\] - participation in PK sampling was voluntary and required consent).","primaryOutcome":{"measure":"Annualized Number of Total Bleeds Within 48 h","timeFrame":"Within 48 hours post infusion","effectByArm":[{"arm":"Main Study - Part A: PTPs 0-<6 Years","deltaMin":2.23,"sd":2.77},{"arm":"Main Study - Part A: PTPs 6-12 Years","deltaMin":1.86,"sd":3.08},{"arm":"Main Study - Part B: PUPs/MTPs 0-<6 Years","deltaMin":1.9,"sd":3.3}],"pValues":[]},"eligibility":{"minAge":"0 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":7},"locations":{"siteCount":43,"countries":["United States","Argentina","Bulgaria","Canada","Denmark","Hungary","Ireland","Israel","Italy","Latvia","Lithuania","Mexico","Norway","Poland","Romania","Russia","Spain"]},"refs":{"pmids":["26931631","26663410","27577234","25952661","27436242","28220555","30013766","32197139","37309365","36626898","39667975"],"seeAlso":["http://www.clinicaltrialsregister.eu/","https://clinicaltrials.bayer.com/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Pyrexia","Nasopharyngitis","Cough","Vomiting","Diarrhoea"]}}